Magnetic nanoparticles engineered T cells inside living mice and guided them into solid tumors, achieving over 90% tumor ...

Neil McIntosh looks at the use of 'monoclonal antibodies', rather than drugs, to treat our pets - especially those with osteoarthritis.

Neil McIntosh looks at the use of 'monoclonal antibodies', rather than drugs, to treat our pets - especially those with ...

For first-degree relatives of patients with Crohn disease, increased antibody response is associated with subsequent risk for CD.

T-cell engagers are antibody-based therapeutics that can reprogram T cells for antigen-specific elimination of target cells. The modality has remained a big draw for Big Pharma, with Eli Lilly penning ...

Urinary system tumors are a group of tumors that occur in the kidney, ureter, bladder and urethra, of which bladder cancer is the most common, followed by ...

By extending a naturally rigid bacterial protein by 50% while preserving geometry and stability, the study introduces protein ...

Point-of-care hepatitis C virus RNA testing significantly increased testing costs compared with previous testing protocols.

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

ITI-5000 utilizes nucleic acid vaccine constructs engineered to preferentially deliver tumor-associated antigens (TAAs) to the MHC II compartment via LAMP-1, potentially enhancing antigen presentation ...

Artificial intelligence (AI) and “protein language” models can speed the design of monoclonal antibodies that prevent or reduce the severity of potentially life-threatening viral infections, according ...

Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or ...